Healthcare stocks rose late Friday afternoon, with the NYSE Healthcare Index increasing 1.2% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 0.8%.
The iShares Biotechnology ETF (IBB) declined 1.8%.
In corporate news, Insmed (INSM) brensocatib shows strong physician conviction alongside a broad prescribing intent that can enable a significant growth opportunity as doctors develop experience with the drug, RBC Capital Markets said Friday. Insmed shares were down 11%.
Ainsworth Game Technology (ASX:AGI) said that Non-Executive Chair Danny Gladstone has resigned with immediate effect following recent media reports concerning personal payments made to him more than eight years ago, according to a Friday filing with the Australian bourse.Gladstone said his resignation was intended to serve the company's best interests by allowing it to move beyond the distraction and focus on its strategic priorities, per the filing.Graeme Campbell has been appointed chair of the board, the filing added.The company's shares rose around 10% in recent Friday trade and earlier hit their highest level since April 2018.
Wealthfront (WLTH) reported fiscal Q1 earnings late Thursday of $0.07 per diluted share, down from $0.18 a year earlier.Analysts polled by FactSet expected EPS of $0.12.Revenue for the quarter ended April 30 was $90.5 million, up from $84.5 million a year earlier.Analysts expected $91.8 million.Shares of Wealthfront were down roughly 9% in after-hours activity.
Samsara (IOT) reported fiscal Q1 non-GAAP earnings late Thursday of $0.17 per diluted share, up from $0.11 a year earlier.Analysts polled by FactSet expected $0.13.Revenue in the three months ended May 2 rose to $478.8 million from $366.9 million a year earlier.Analysts expected $455.2 million.Samsara expects Q2 adjusted EPS of $0.15 to $0.16 on revenue of $482 million to $484 million.Analysts project EPS of $0.15 on revenue of $480.1 million.The company expects full-year adjusted EPS of $0.70 to $0.72 on revenue of $2.005 billion to $2.03 billion. Analysts project EPS of $0.68 on revenue of $1.97 billion.Samsara shares fell 3.2% in after-hours trading.